Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content
- PMID: 3080587
Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content
Abstract
Piperine (1-peperoyl piperidine), a major component of the Piper species was reported recently by us to inhibit the activities of rat hepatic monooxygenases and UDP-glucuronyltransferase. This study explores further the basis of inhibition of glucuronidation. The effect of piperine on the rate of glucuronidation of 3-hydroxybenzo(a) pyrene and UDP-glucuronic acid content in the intact isolated epithelial cells of the guinea-pig small intestine was studied. The cells offered a fairly good system to study the modulation of glucuronidation activity. Glucuronidation of 3-hydroxybenzo(a) pyrene was dependent on the time of incubation, cellular protein and substrate concentration. From the kinetics of glucuronidation of 3-hydroxybenzo(a)pyrene in the isolated cell preparation the Vmax of 0.5 nmol of BP-3-glucuronide formed per min/mg of protein and Km of 25 microM were observed. The endogeneous concentration of UDP-glucuronic acid observed was 1.6 to 2.3 nmol/mg of cellular protein. Piperine caused a concentration-related decrease in UDP-glucuronic acid content and the rate of glucuronidation in the cells. It required much lower concentrations of piperine than D-galactosamine to diminish the endogeneous level of UDP-glucuronic acid. Rate of glucuronidation of 3-hydroxybenzo (a) pyrene was dependent on the endogeneous level of UDP-glucuronic acid. At 50 microM piperine, the rate of glucuronidation was reduced to about 50% of the basal rate. Piperine caused noncompetitive inhibition of hepatic microsomal UDP-glucuronyltransferase with Ki of 70 microM. The studies demonstrate that piperine modifies the rate of glucuronidation by lowering the endogeneous UDP-glucuronic acid content and also by inhibiting the transferase activity.
Similar articles
-
Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine.Biochem Pharmacol. 1993 Jul 20;46(2):229-38. doi: 10.1016/0006-2952(93)90408-o. Biochem Pharmacol. 1993. PMID: 8347144
-
Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.Indian J Exp Biol. 1997 Mar;35(3):256-63. Indian J Exp Biol. 1997. PMID: 9332170
-
Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.Cancer Res. 1991 Sep 1;51(17):4511-5. Cancer Res. 1991. PMID: 1908348
-
Mechanistic and molecular aspects of hepatic bilirubin glucuronidation.Prog Liver Dis. 1990;9:225-35. Prog Liver Dis. 1990. PMID: 2156293 Review. No abstract available.
-
Developmental aspects of drug conjugation, with special reference to glucuronidation.Annu Rev Pharmacol Toxicol. 1978;18:17-35. doi: 10.1146/annurev.pa.18.040178.000313. Annu Rev Pharmacol Toxicol. 1978. PMID: 417666 Review. No abstract available.
Cited by
-
The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism.Daru. 2014 Jan 7;22(1):8. doi: 10.1186/2008-2231-22-8. Daru. 2014. PMID: 24398010 Free PMC article.
-
Bioenhancers: Revolutionary concept to market.J Ayurveda Integr Med. 2010 Apr;1(2):96-9. doi: 10.4103/0975-9476.65073. J Ayurveda Integr Med. 2010. PMID: 21836795 Free PMC article.
-
An appraisal of the bioavailability enhancers in Ayurveda in the light of recent pharmacological advances.Ayu. 2016 Jan-Mar;37(1):3-10. doi: 10.4103/ayu.AYU_11_15. Ayu. 2016. PMID: 28827948 Free PMC article. Review.
-
Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.AAPS J. 2017 Jan;19(1):54-81. doi: 10.1208/s12248-016-0003-2. Epub 2016 Oct 25. AAPS J. 2017. PMID: 27783266 Review.
-
Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.MedComm (2020). 2021 Aug 5;2(4):494-513. doi: 10.1002/mco2.82. eCollection 2021 Dec. MedComm (2020). 2021. PMID: 34977867 Free PMC article. Review.